Saudi Arabia/The Race to 2030
Data updated: 2026-05-29
Vision 2030 · Health Sector

The Race to 2030

A scroll-driven look at how Saudi Arabia's health transformation is tracking against its 2030 targets - 1 achieved, 6 on track, across 8 key indicators.

Scroll to begin the story

Health Transformation Funding

Vision 2030 health budget allocation · SAR billions

B SARin 2018
2016 · Vision 2030 launches

A decade-long bet on health

Vision 2030 launched in April 2016 with measurable health targets - but zero dedicated health-transformation funding in Year 1. The real money came next.

The investment ramp

From SAR 12B to SAR 68B in eight years

Dedicated health-transformation spending climbed every budget cycle - financing new hospitals, a larger workforce, digital health infrastructure, and the NPHIES claims exchange.

Outcomes · 1 of 8

People are living 2.4 years longer

Life expectancy rose from 74.4 years at baseline to 76.8 - steadily closing on the 80-year goal. Better primary care and chronic-disease management are driving the gain.

Workforce · 2 of 8

A homegrown health workforce, nearly doubled

Saudization of the health sector jumped from 19% to 35%, on track for 40% by 2030 - reducing reliance on expatriate staff and building lasting national capacity.

Financing · 3 of 8

Private capital crossed the line four years early

The private sector now funds 36.6% of health spending - already past the 35% target. Privatization and FDI in healthcare are ahead of schedule.

Capacity · 4 of 8

Doctors and beds are scaling steadily

Physician density reached 2.74 per 1,000 (target 3.0) and primary care centers grew toward the 3,000 goal - expanding access across all 13 regions.

The frontier · at risk

One goal is falling behind: local pharma

Local pharmaceutical manufacturing sits at 22% against a 40% target - the Kingdom still imports most of its medicines. This is the transformation’s hardest, most strategic gap.

The scorecard

One target achieved, six on track, one at risk

Across eight tracked health indicators, Vision 2030 is broadly on course - with localized pharmaceutical production the clear priority for the second half of the decade.

Explore the underlying data

Every figure here is drawn from official MOH and GASTAT statistics. Dive into the full dashboards for demographics, infrastructure, workforce, and finance.

Disclaimer

This platform is an independent, non-commercial data visualization project. It is not affiliated with, endorsed by, or produced by the Ministry of Health of Saudi Arabia, the General Authority for Statistics (GASTAT), the World Bank, the World Health Organization (WHO), or any other government body or institution.

All data presented is sourced exclusively from publicly available official publications, including MOH Statistical Yearbooks, GASTAT health statistics reports, World Bank Open Data, and WHO Global Health Observatory. Statistical figures are reproduced as-is for informational and educational purposes. No personal, patient, or individually identifiable data is collected, stored, or displayed.

While every effort has been made to ensure accuracy, the data may not reflect the most recent figures. Users should refer to the original source publications for authoritative and up-to-date statistics. This platform does not constitute medical, financial, or policy advice.

Data sources: MOH · GASTAT · World Bank · WHO · Last aggregated: May 2026

Healthcare Intelligence Assistant
Powered by 32 Saudi healthcare sources

Ask me anything about

Saudi Arabia's healthcare system

Suggested questions

Shift+Enter for new line · Enter to send